Log in to save to my catalogue

Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nan...

Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_952995b39ff94d00a533dbb89c7a3355

Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nanoparticles) against cystic echinococcosis

About this item

Full title

Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nanoparticles) against cystic echinococcosis

Publisher

England: BioMed Central Ltd

Journal title

BMC infectious diseases, 2024-08, Vol.24 (1), p.778-17, Article 778

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Albendazole (ABZ) and atovaquone (ATO) achieve killing efficacy on Echinococcus granulosus (Egs) by inhibiting energy metabolism, but their utilization rate is low. This study aims to analyze the killing efficacy of ABZ-ATO loading nanoparticles (ABZ-ATO NPs) on Egs.
Physicochemical properties of NPs were evaluated by ultraviolet spectroscopy an...

Alternative Titles

Full title

Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nanoparticles) against cystic echinococcosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_952995b39ff94d00a533dbb89c7a3355

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_952995b39ff94d00a533dbb89c7a3355

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-024-09662-w

How to access this item